IVAX Diagnostics (IVD)
IVAX Diagnostics Market Cap: 19.95M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
IVD Market Cap Rankings
| Overall | 6th percentile | 4364 of 4663 |
| Sector | 9th percentile | 477 of 525 in Healthcare |
| Industry | 7th percentile | 63 of 68 in Medical Instruments & Supplies |
IVD Market Cap Range, Past 5 Years
| Minimum | 9.124M | Mar 2009 |
| Maximum | 28.48M | Jun 2007 |
| Average | 17.02M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these IVD related companies
IVD News
$IVD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3yp7
about 6 days ago by MarketBrief
about 6 days ago by MarketBrief
URGENT: $IVD filed to delay releasing quarterly earnings results (SEC Filing Form NT 10Q) http://stks.co/3rQn
about 14 days ago by MarketBrief
about 14 days ago by MarketBrief
IVAX Diagnostics, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results
Apr 16, 5:57PM Business Wire
Apr 16, 5:57PM Business Wire
URGENT: $IVD filed to delay releasing annual earnings results (SEC Filing Form NT 10K) http://stks.co/3Bo3
about 58 days ago by MarketBrief
about 58 days ago by MarketBrief
IVAX Diagnostics (IVD) Announces Amendment to Stock Purchase Agreement with ERBA Diagnostics Mannheim GmbH
Dec 29, 5:17PM Street Insider
Dec 29, 5:17PM Street Insider
URGENT: $IVD filed to delay releasing quarterly earnings results (SEC Filing Form NT 10Q) http://stks.co/18sK
about 197 days ago by MarketBrief
about 197 days ago by MarketBrief
Ivax Diagnostics announces initial closing of investment, plans to expand
Jul 05, 9:47AM FlyOnTheWall
Jul 05, 9:47AM FlyOnTheWall
IVAX Diagnostics Announces Initial Closing of Investment and Prepares for Expansion and Acquisitions
Jul 05, 8:45AM Business Wire
Jul 05, 8:45AM Business Wire
Ivax Diagnostics: Our policy is not to comment on unusual market activity
Jun 14, 2:45PM FlyOnTheWall
Jun 14, 2:45PM FlyOnTheWall
IVAX Diagnostics Confirms That Its Policy is Not to Comment on Unusual Market Activity
Jun 14, 1:44PM Business Wire
Jun 14, 1:44PM Business Wire
$IVD bashers trying to spread false panic that aint there. $IVD when it shoots up will leave all bashers brushing up on their fear tactics
about 429 days ago by pumpndumphunter
about 429 days ago by pumpndumphunter
$IVD this is why I scalp..in and out quick.perfect example rt here!
about 429 days ago by Devildog0311
about 429 days ago by Devildog0311
IVAX $IVD Reports Q4 Loss of 3c; Sees Filing Containing 'Going Concern', to Evaluate Forms of Debt, Equity Financing
about 429 days ago by Street_Insider
about 429 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IVD | 0.5801 | +0.00 | +0.00% | 19.95M |
| IVAN | 0.76 | -0.02 | -2.56% | 268.43M |
| IVAC | 7.79 | -0.09 | -1.14% | 183.29M |
| ITW | 55.98 | -1.22 | -2.13% | 27.54B |
| ITUB | 13.97 | -0.31 | -2.17% | 65.26B |
| ITT | 20.49 | -0.42 | -2.01% | 1.984B |
| ITRN | 11.60 | -1.09 | -8.59% | 297.96M |
| ITRI | 35.43 | -1.19 | -3.25% | 1.463B |
| ITR | 33.93 | +0.11 | +0.33% | |
| ITMN | 10.26 | -0.84 | -7.57% | 725.16M |
